newsroom.mylan.comNews | Mylan

Close Location Selector Visit the global site - Mylan.com Australia Austria Belgium fr nl Brazil Bulgaria Canada en fr Croatia Czech Republic Denmark Finland France Germany Greece Hungary India Ireland Italy Japan Malaysia Netherlands New Zealand Norway Poland Portugal Romania Serbia Slovakia Slovenia South Africa Spain Sweden Switzerland De En Taiwan Thailand United Kingdom United States About Mylan Better Health Business Segments Leadership Corporate Governance Products Biosimilars Generics Brand Over-the-Counter API Product Catalog News Press Releases Feature Stories Mylan in the News Resources Fact Sheets Investors Leadership Corporate Governance Latest News Events and Presentations Financials and filings Stock Information Shareholder Toolkit Contact Us Stock History Investment Calculator Stock Performance Social Responsibility Serving Patients Engaging Employees Environmental Stewardship Advocating for Access Forging Partnerships Supporting Communities Oversight and Compliance Careers Life at Mylan Mylan Benefits Diversity and inclusion Mylan Near You Mylan Worldwide News Press Releases Feature Stories Mylan In The News Resources Fact Sheets News Latest News Jul 9, 2020 Viatris Reveals Branding to Reflect New Company’s Transformative Strategy Mylan N.V. (NASDAQ: MYL) and Upjohn, a division of Pfizer, today unveiled the logo and branding for VIATRIS™, the new company that will be formed by combining Mylan and Upjohn. Experience the... Jul 9, 2020 Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp) Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hulio® (adalimumab-fkjp), a biosimilar to... Jul 7, 2020 Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to the Presence of Particulate Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for... Jul 6, 2020 Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients Mylan N.V. (NASDAQ: MYL) today announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI’s... Jun 30, 2020 Mylan Shareholders Overwhelmingly Approve Proposed Combination with Upjohn Mylan N.V. (Nasdaq: MYL) today announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a division of Pfizer, at the company’s... View More Search News Releases Contact Mylan Communications Global Communications 724.514.1968 communications@mylan.com Stay Connected Email Alerts Follow Us Share About Mylan Better Health Business Segments Leadership Corporate Governance Social Responsibility Products Biosimilars Generics Brand Over-the-Counter API Product Catalog News Press Releases Feature Stories Mylan In the News Resources Fact Sheets Investors Financials and Filings Stock History Investment Calculator Stock Performance Careers Life at Mylan Mylan Benefits Diversity and Inclusion Mylan Near You Contact Mylan Privacy Shield Policy Privacy Statement Terms and Conditions Site Map California Supply Chains Act Follow Us ©2020 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc. You are leaving Mylan.com By clicking Continue below you are leaving Mylan.com and going to a third-party site. Continue Go...